Author

M. Le Bideau

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 2 Assay:clinical cohort / trial· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

B. La Scola· 3 shared D. Raoult· 2 shared J. Y. Bou Khalil· 2 shared R. Francis· 2 shared A. Bancod· 1 shared C. Boschi· 1 shared C. Grimaldier· 1 shared D. E. Scheim· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

B. La Scola

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

BiochemistrybioRxivPreprintNov 24, 2022

SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Effects

C. Boschi, D. E. Scheim, A. Bancod…·B. La Scola

This study shows SARS-CoV-2 spike proteins from four lineages induce hemagglutination, with Omicron requiring lower concentrations, and ivermectin inhibits this effect, suggesting therapeutic and safety implications.

DOI 10.1101/2022.11.24.517882

humanproteomics

MicrobiologybioRxivMay 14, 2020

High speed large scale automated isolation of SARS-CoV-2 from clinical samples using miniaturized co-culture coupled with high content screening

R. Francis, M. Le Bideau, P. Jardot…·B. La Scola

This paper presents a high-content screening method for rapid and automated isolation of SARS-CoV-2 from clinical samples, achieving comparable isolation rates to traditional methods but with faster results and reduced contamination risks.

DOI 10.1016/j.cmi.2020.09.018

humanclinical cohort / trial

MicrobiologybioRxivDec 17, 2019

High Content Screening, a reliable system for Coxiella burnetii isolation from clinical samples

R. Francis, M. Mioulane, M. Le Bideau…·B. La Scola

This paper develops a high content screening (HCS) method for isolating Coxiella burnetii from clinical samples, showing higher sensitivity and efficiency compared to traditional shell-vial assays.

DOI 10.1128/jcm.02081-19

experimental assay